XML 45 R34.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2024
Stockholders' Equity Note [Abstract]  
Schedule of Designated Preferred Units As of March 31, 2024, the Company has designated the following preferred stock:
Designated Preferred SharesMarch 31, 2024
Series A4,200 
Series B2,360 
Series C590 
Series D10,000 
Series E 40,000 
Series E-112,960 
Series F-1 24,900 
Series F-224,900 
Series F-334,860 
Series F-424,900 
Total179,670 
Summary of Avenue Warrant Valued Using the Black-Scholes Option Pricing Method
The Company values stock options using the Black-Scholes option pricing model and used the following assumptions, on a weighted-average basis, during the reporting periods:
 Three Months Ended March 31,
 20242023
Expected terms (years)5.65.8
Expected volatility115.0%172.8%
Risk-free interest rate4.19%4.08%
Expected dividends0.00%0.00%
Summary of Stock Option Activity
The following is a summary of stock option activity for the three months ended March 31, 2024:
Number of Options Weighted Average
Exercise Price Per Share
Weighted Average Grant Date Fair Value Per ShareWeighted Average
Remaining
Contractual Term
(in years)
Aggregate Intrinsic
Value
(in thousands)
Outstanding at January 1, 20244,183,232$8.17 $7.60 8.3$147 
Granted2,017,5964.80 3.929.7
Exercised— — — — 
Expired(15,341)7.16 6.91
Cancelled/Forfeited(146,312)6.08 5.75
Outstanding at March 31, 20246,039,175$7.10 $6.42 8.6$433 
Exercisable at March 31, 20242,569,497$9.47 $8.73 7.4$74 
Unvested at March 31, 20243,469,678 $5.34 $4.70 9.4$358 
Summary of Stock Option Shares Outstanding and Exercisable
The following table summarizes information for stock option shares outstanding and exercisable at March 31, 2024:
Options Outstanding
Range of Exercise PricesOutstanding Number of
Options
Weighted Average
Remaining Option Term
(in years)
Number of Options
$2.83 - $51.50
6,038,6768.66,038,676
$51.50+
4994.8499
6,039,1758.66,039,175
Summary of Recognized Share-based Compensation Cost
The following is a summary of share-based compensation expense in the statement of operations for the three months ended March 31, 2024:
Three Months Ended March 31,
(In thousands)20242023
Selling, general and administrative$2,042 $1,118 
Research and development647 417 
Cost of goods sold256 126 
Total$2,945 $1,661 
Summary of Warrant Activity
The following is a summary of common stock warrant activity for the three months ended March 31, 2024:
 Warrants
Weighted Average Exercise Price
Weighted Average
Remaining Life
(in years)
Outstanding at January 1, 20244,665,201$7.76 1.6
Warrants issued1,008,1020.01 5.0
Warrants exercised— — 
Outstanding at March 31, 20245,673,3032.0
Exercisable at March 31, 20245,673,303$6.39 2.0
The following is a summary of preferred stock warrant activity for the three months ended March 31, 2024:
WarrantsWeighted Average Exercise PriceWeighted Average
Remaining Life
(in years)
Outstanding at January 1, 202424,900 $1,000 2.3
Warrants issued— 
Warrants exercised— 
Outstanding at March 31, 202424,900$1,000 2.0
Exercisable at March 31, 202424,900$1,000 2.0
Schedule of Information Related to Stock Warrants Outstanding and Exercisable
The following table presents information related to common stock warrants outstanding at March 31, 2024:
Warrants Exercisable
Range of Exercise PricesOutstanding
Number of
Warrants
Weighted Average
Remaining Warrant Term
(in years)
Number of Warrants
$0.012,045,8944.02,045,894
$6.00
16,6662.016,666
$10.003,610,7431.03,610,743
5,673,3032.05,673,303